RxDoctor Payments Data

Teresa Sirois

Family · Topsham, MENPI 1396779757

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,662 of the $1,861 with a category attached, or 89.3%. It is spread thinly across 26 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $722, 4.6 times the $159 reported in 2021. Among family clinicians in ME with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,861in general payments, 2019–2025

Across 64 payments — averaging $29.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$242
  • Johnson & Johnson$214
  • Incyte Corporation$212
  • AbbVie$207
  • Pharmacyclics LLC, An Abbvie Company$179
  • Mirati Therapeutics, Inc.$114
  • plus $692 from 20 others

What the payments were for

  • Food & beverage$1,66289%
  • Education$19911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,861 in reported general payments places this provider in the 90th percentile of 545 family providers in Maine.

See all family providers in Maine

Medicare billing

Part B allowed, 2024
$86,186
Medicare patients
115
Services billed
4,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$20,854
Fentanyl35$4,702
Ondansetron OdtOndansetron68$1,250
Morphine Sulfate22$1,053
Oxycodone Hcl58$689
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine16$659
Prochlorperazine Maleate45$461
Acyclovir21$439
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$397
Potassium Chloride39$372
Dexamethasone20$356
Testosterone Cypionate22$294
Letrozole12$210
Prednisone42$204
Lorazepam33$180

Paid to pharmacies, not to this prescriber.

Other family in Topsham

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →